Literature DB >> 12791782

Enhanced drop-in syndromic surveillance in New York City following September 11, 2001.

Debjani Das1, Don Weiss, Farzad Mostashari, Tracee Treadwell, Jennifer McQuiston, Lori Hutwagner, Adam Karpati, Katherine Bornschlegel, Mathew Seeman, Reina Turcios, Pauline Terebuh, Robin Curtis, Richard Heffernan, Sharon Balter.   

Abstract

After the 2001 World Trade Center disaster, the New York City Department of Health was under heightened alert for bioterrorist attacks in the city. An emergency department (ED) syndromic surveillance system was implemented with the assistance of the Centers for Disease Control and Prevention to ensure early recognition of an increase or clustering of disease syndromes that might represent a disease outbreak, whether natural or intentional. The surveillance system was based on data collected 7 days a week at area EDs. Data collected were translated into syndromes, entered into an electronic database, and analyzed for aberrations in space and time within 24 hours. From September 14-27, personnel were stationed at 15 EDs on a 24-hour basis (first staffing period); from September 29-October 12, due to resource limitations, personnel were stationed at 12 EDs on an 18-hour basis (second staffing period). A standardized form was used to obtain demographic information and classify each patient visit into 12 syndrome categories. Seven of these represented early manifestations of bioterrorist agents. Data transfer and analysis for time and space clustering (alarms) by syndrome and age occurred daily. Retrospective analyses examined syndrome trends, differences in reporting between staffing periods, and the staff's experience during the project. A total of 67,536 reports were received. The system captured 83.9% of patient visits during the first staffing period, and 60.8% during the second staffing period (P < 0.01). Five syndromes each accounted for more than 1% of visits: trauma, asthma, gastrointestinal illness, upper/lower respiratory infection with fever, and anxiety. Citywide temporal alarms occurred eight times for three of the major bioterrorism-related syndromes. Spatial clustering alarms occurred 16 times by hospital location and 9 times by ZIP code for the same three syndromes. No outbreaks were detected. On-site staffing to facilitate data collection and entry, supported by daily analysis of ED visits, is a feasible short-term approach to syndromic surveillance during high-profile events. The resources required to operate such a system, however, cannot be sustained for the long term. This system was changed to an electronic-based ED syndromic system using triage log data that remains in operation.

Entities:  

Mesh:

Year:  2003        PMID: 12791782      PMCID: PMC3456534          DOI: 10.1007/pl00022318

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  6 in total

Review 1.  Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.

Authors:  T V Inglesby; D T Dennis; D A Henderson; J G Bartlett; M S Ascher; E Eitzen; A D Fine; A M Friedlander; J Hauer; J F Koerner; M Layton; J McDade; M T Osterholm; T O'Toole; G Parker; T M Perl; P K Russell; M Schoch-Spana; K Tonat
Journal:  JAMA       Date:  2000-05-03       Impact factor: 56.272

Review 2.  Hemorrhagic fever viruses as biological weapons: medical and public health management.

Authors:  Luciana Borio; Thomas Inglesby; C J Peters; Alan L Schmaljohn; James M Hughes; Peter B Jahrling; Thomas Ksiazek; Karl M Johnson; Andrea Meyerhoff; Tara O'Toole; Michael S Ascher; John Bartlett; Joel G Breman; Edward M Eitzen; Margaret Hamburg; Jerry Hauer; D A Henderson; Richard T Johnson; Gigi Kwik; Marci Layton; Scott Lillibridge; Gary J Nabel; Michael T Osterholm; Trish M Perl; Philip Russell; Kevin Tonat
Journal:  JAMA       Date:  2002-05-08       Impact factor: 56.272

Review 3.  Anthrax as a biological weapon, 2002: updated recommendations for management.

Authors:  Thomas V Inglesby; Tara O'Toole; Donald A Henderson; John G Bartlett; Michael S Ascher; Edward Eitzen; Arthur M Friedlander; Julie Gerberding; Jerome Hauer; James Hughes; Joseph McDade; Michael T Osterholm; Gerald Parker; Trish M Perl; Philip K Russell; Kevin Tonat
Journal:  JAMA       Date:  2002-05-01       Impact factor: 56.272

Review 4.  Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.

Authors:  D A Henderson; T V Inglesby; J G Bartlett; M S Ascher; E Eitzen; P B Jahrling; J Hauer; M Layton; J McDade; M T Osterholm; T O'Toole; G Parker; T Perl; P K Russell; K Tonat
Journal:  JAMA       Date:  1999-06-09       Impact factor: 56.272

Review 5.  Tularemia as a biological weapon: medical and public health management.

Authors:  D T Dennis; T V Inglesby; D A Henderson; J G Bartlett; M S Ascher; E Eitzen; A D Fine; A M Friedlander; J Hauer; M Layton; S R Lillibridge; J E McDade; M T Osterholm; T O'Toole; G Parker; T M Perl; P K Russell; K Tonat
Journal:  JAMA       Date:  2001-06-06       Impact factor: 56.272

6.  Dead bird clusters as an early warning system for West Nile virus activity.

Authors:  Farzad Mostashari; Martin Kulldorff; Jessica J Hartman; James R Miller; Varuni Kulasekera
Journal:  Emerg Infect Dis       Date:  2003-06       Impact factor: 6.883

  6 in total
  16 in total

1.  Automated syndromic surveillance for the 2002 Winter Olympics.

Authors:  Per H Gesteland; Reed M Gardner; Fu-Chiang Tsui; Jeremy U Espino; Robert T Rolfs; Brent C James; Wendy W Chapman; Andrew W Moore; Michael M Wagner
Journal:  J Am Med Inform Assoc       Date:  2003-08-04       Impact factor: 4.497

2.  The Indiana Public Health Emergency Surveillance System: ongoing progress, early findings, and future directions.

Authors:  Shaun Grannis; Michael Wade; Joseph Gibson; J Marc Overhage
Journal:  AMIA Annu Symp Proc       Date:  2006

3.  Using Syndromic Surveillance for All-Hazards Public Health Surveillance: Successes, Challenges, and the Future.

Authors:  Paula W Yoon; Amy I Ising; Julia E Gunn
Journal:  Public Health Rep       Date:  2017 Jul/Aug       Impact factor: 2.792

Review 4.  The role of epidemiology in disaster response policy development.

Authors:  Lorna E Thorpe; Shervin Assari; Stephen Deppen; Sherry Glied; Nicole Lurie; Matthew P Mauer; Vickie M Mays; Edward Trapido
Journal:  Ann Epidemiol       Date:  2014-07-03       Impact factor: 3.797

5.  Exploring national surveillance for health-related workplace absenteeism: lessons learned from the 2009 influenza A pandemic.

Authors:  Matthew R Groenewold; Doris L Konicki; Sara E Luckhaupt; Ahmed Gomaa; Lisa M Koonin
Journal:  Disaster Med Public Health Prep       Date:  2013-04       Impact factor: 1.385

6.  The value of patient self-report for disease surveillance.

Authors:  Florence T Bourgeois; Stephen C Porter; Clarissa Valim; Tiffany Jackson; E Francis Cook; Kenneth D Mandl
Journal:  J Am Med Inform Assoc       Date:  2007-08-21       Impact factor: 4.497

7.  Implementing syndromic surveillance: a practical guide informed by the early experience.

Authors:  Kenneth D Mandl; J Marc Overhage; Michael M Wagner; William B Lober; Paola Sebastiani; Farzad Mostashari; Julie A Pavlin; Per H Gesteland; Tracee Treadwell; Eileen Koski; Lori Hutwagner; David L Buckeridge; Raymond D Aller; Shaun Grannis
Journal:  J Am Med Inform Assoc       Date:  2003-11-21       Impact factor: 4.497

8.  Probabilistic case detection for disease surveillance using data in electronic medical records.

Authors:  Fuchiang Tsui; Michael Wagner; Gregory Cooper; Jialan Que; Hendrik Harkema; John Dowling; Thomsun Sriburadej; Qi Li; Jeremy U Espino; Ronald Voorhees
Journal:  Online J Public Health Inform       Date:  2011-12-22

9.  Syndromic surveillance.

Authors:  Zygmunt F Dembek; Dennis G Cochrane; Julie A Pavlin
Journal:  Emerg Infect Dis       Date:  2004-07       Impact factor: 6.883

Review 10.  Spatial epidemiology: current approaches and future challenges.

Authors:  Paul Elliott; Daniel Wartenberg
Journal:  Environ Health Perspect       Date:  2004-06       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.